Market Overview The global market for 1,3-butylene glycol is projected to generate approximately USD 188.8 million in revenue by 2024, with an expected growth rate of over 6.1% CAGR from 2024 to 2030, reaching USD 269.1 million by 2030.
The global acute conjunctivitis treatment market size was valued at USD 4.8 billion in 2022 and is anticipated to grow at USD 6.5 billion by 2029 recording a CAGR of 4.0% from the forecast period 2023-2029.
